Key publications
All Publications
- de Laat Myrthe M., Wind Carolien M., Bruisten Sylvia M., Dierdorp Mirjam, de Vries Henry J. C., Schim van der Loeff Maarten F., van Dam Alje P. Ceftriaxone Reduced Susceptible Neisseria gonorrhoeae in the Netherlands, 2009 to 2017: From PenA Mosaicism to A501T/V Nonmosaicism Sexually transmitted diseases 2019;46 (9):594-601 [PubMed]
- Wind Carolien M., Bruisten Sylvia M., Schim van der Loeff Maarten F., Dierdorp Mirjam, de Vries Henry J. C., van Dam Alje P. A Case-Control Study of Molecular Epidemiology in Relation to Azithromycin Resistance in Neisseria gonorrhoeae Isolates Collected in Amsterdam, the Netherlands, between 2008 and 2015 Antimicrobial agents and chemotherapy 2017;61 (6):e02374-16 [PubMed]
- Wind Carolien M., de Vries Henry J. C., Schim van der Loeff Maarten F., Unemo Magnus, van Dam Alje P. Successful Combination of Nucleic Acid Amplification Test Diagnostics and Targeted Deferred Neisseria gonorrhoeae Culture Journal of clinical microbiology 2015;53 (6):1884-1890 [PubMed]
- Wind Carolien M., de Vries Henry J. C., van Dam Alje P. Determination of in vitro synergy for dual antimicrobial therapy against resistant Neisseria gonorrhoeae using Etest and agar dilution International journal of antimicrobial agents 2015;45 (3):305-308 [PubMed]
- van Dam Alje P., van Ogtrop Marc L., Golparian Daniel, Mehrtens Jan, de Vries Henry J. C., Unemo Magnus Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report Sexually transmitted infections 2014;90 (7):513-514 [PubMed]
Research programmes
Prof. MD PhD H.J.C. de Vries (Sexually Transmitted and Emerging Skin Infections)